Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: J Biomed Mater Res A. 2013 Jun 7;102(5):1305–1315. doi: 10.1002/jbm.a.34807

Figure 4.

Figure 4

Illustrations of fibrovascular ingrowth into porous implants. Implant sections are stained with haematoxylin and basic fuchsin. A: Bacterial colonization (arrows) of the surface crust; bacteria were not identified in the pores of the implant (Nano implant, 6 weeks, SD rat, magnification 200x). B: Small vessels (arrows) in fibrous tissue inside implant pores (Large implant, 4 weeks, CD rat, magnification 200x). C: The innermost pores of the device show diffuse fibrovascular ingrowth without significant inflammation (Nano implant, 6 weeks, SD rat, magnification 200x). D: Poor tissue ingrowth (*) into pores of the implant adjacent to a focus of granulomatous inflammation (dashed lines) (Small implant, 6 weeks, SD rat, magnification 40x). E: Mononuclear infiltrates (*) extending into the pores of the periphery of the implant (Nano implant, 6 weeks, SD rat, magnification 200×).